UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000046839
Receipt No. R000053439
Scientific Title Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study
Date of disclosure of the study information 2022/02/06
Last modified on 2022/08/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study
Acronym Impact of HFT on perioperative complication rate in hip fracture co-management by hospitalists
Scientific Title Impact of a hip fracture template on perioperative complication rate in hip fracture co-management by hospitalists: a retrospective cohort study
Scientific Title:Acronym Impact of HFT on perioperative complication rate in hip fracture co-management by hospitalists
Region
Japan

Condition
Condition hip fracture
Classification by specialty
Medicine in general Orthopedics Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We examined its effect on morbidity in patients with hip fractures and the factors associated with complications.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes perioperative complication rate
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients who underwent surgery for hip fracture in Akashi medical center between July 2020 and September 2021
Key exclusion criteria patients with periprosthetic fracture
Target sample size 243

Research contact person
Name of lead principal investigator
1st name Naoto
Middle name
Last name Ishimaru
Organization Akashi Medical Center
Division name Department of General Internal Medicine
Zip code 6740063
Address 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan
TEL 0789361101
Email maru-tkb@umin.ac.jp

Public contact
Name of contact person
1st name Naoto
Middle name
Last name Ishimaru
Organization Akashi Medical Center
Division name Department of General Internal Medicine
Zip code 6740063
Address 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan
TEL 0789361101
Homepage URL
Email maru-tkb@umin.ac.jp

Sponsor
Institute Akashi Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Akashi Medical Center
Address 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan
Tel 0789361101
Email yokoyama.naoki@aijinkai-group.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 12 Month 23 Day
Date of IRB
2022 Year 01 Month 24 Day
Anticipated trial start date
2022 Year 01 Month 27 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Demographic data, items used in the template, and comorbidities were obtained from patient's charts.

Management information
Registered date
2022 Year 02 Month 06 Day
Last modified on
2022 Year 08 Month 08 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053439